Genomic Valley Biotech Ltd vs Kesar Terminals Infrastructure Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 28.56 as of 20 Mar 15:30 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Kesar Terminals & Infrastructure Ltd changed from 9.6 on March 2025 to 9.6 on March 2025 . This represents a CAGR of 0.00% over 1 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Kesar Terminals & Infrastructure Ltd changed from ₹ 36.88 crore on March 2021 to ₹ 77.09 crore on March 2025 . This represents a CAGR of 15.89% over 5 years The revenue of Genomic Valley Biotech Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Kesar Terminals & Infrastructure Ltd for the Jun '25 is ₹ 8.16 crore as compare to the Mar '25 revenue of ₹ 9.8 crore. This represent the decline of -16.73% The ebitda of Genomic Valley Biotech Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Kesar Terminals & Infrastructure Ltd for the Jun '25 is ₹ -6.68 crore as compare to the Mar '25 ebitda of ₹ 3.47 crore. This represent the decline of -292% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The net profit of Kesar Terminals & Infrastructure Ltd changed from ₹ -8.58 crore to ₹ -17.37 crore over 5 quarters. This represents a CAGR of 75.81% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kesar Terminals & Infrastructure Ltd changed from 13.85 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About Kesar Terminals & Infrastructure Ltd

Kesar Terminals & Infrastructure Limited (KTIL) was incorporated on January 21, 2008 as a wholly owned subsidiary of Kesar Enterprises Ltd. (KEL).
The Company was a pioneer in offering bulk liquid terminal services for various Importers and Exporters of Chemical Products, Petro-Chemicals, Edible and Non-Edible Oils and Petroleum Products. As per the Scheme of Arrangement for Demerger, the Storage Division of Kesar Enterprises Ltd (KEL) was demerged and transferred to the Company as a going concern effective from January 1, 2009.
The said Scheme became effective on March 29, 2010 and the Company ceased to be subsidiary of Kesar Enterprises Ltd effective from June 1, 2010.
Pursuant to the Scheme of Demerger, in consideration of the transfer of Storage Undertaking into the Company, 47,53,113 Equity Shares of Rs.

FAQs for the comparison of Genomic Valley Biotech Ltd and Kesar Terminals & Infrastructure Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or Kesar Terminals & Infrastructure Ltd?

Market cap of Genomic Valley Biotech Ltd is 8 Cr while Market cap of Kesar Terminals & Infrastructure Ltd is 66 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and Kesar Terminals & Infrastructure Ltd?

The stock performance of Genomic Valley Biotech Ltd and Kesar Terminals & Infrastructure Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and Kesar Terminals & Infrastructure Ltd?

As of March 23, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹28.56. On the other hand, Kesar Terminals & Infrastructure Ltd stock price is INR ₹60.4.

How do dividend payouts of Genomic Valley Biotech Ltd and Kesar Terminals & Infrastructure Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and Kesar Terminals & Infrastructure Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.